NeuroSense Therapeutics Ltd. (NRSN) SEC Filings & Financial Intelligence
NeuroSense Therapeutics Ltd. (NRSN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NRSN
CIK: 1875091
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Somekh Chaikin
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerHila Pearl (Bashari)
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-13 | 2026-10-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108759 | View SEC Doc Filr Page |
| 6-K | 2026-10-02 | 2026-10-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-106388 | View SEC Doc Filr Page |
| 6-K | 2026-09-25 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-103534 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098414 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-094389 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-088851 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086007 | View SEC Doc Filr Page |
| EFFECT | 2026-07-31 | — | EFFECT Filing | 9999999995-26-002505 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083987 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083984 | View SEC Doc Filr Page |
| F-3/A | 2026-07-30 | — | AMENDMENT NO. 1 TO FORM F-3 | 0001213900-26-083328 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-07-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-080203 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-072907 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-071799 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001213900-26-069663 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 Filing | 0001213900-26-069662 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-067577 | View SEC Doc Filr Page |
| 6-K | 2026-06-09 | 2026-06-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-066582 | View SEC Doc Filr Page |
| 6-K | 2026-06-08 | 2026-06-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-066077 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-048513 | View SEC Doc Filr Page |
| 6-K | 2026-04-24 | 2026-04-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-047292 | View SEC Doc Filr Page |
| 6-K | 2026-04-06 | 2026-04-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-040185 | View SEC Doc Filr Page |
| 6-K | 2026-04-03 | 2026-04-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-039734 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-26 | OWNERSHIP DOCUMENT | 0001213900-26-038545 | View SEC Doc Filr Page |
| 3 | 2026-04-01 | 2026-03-18 | OWNERSHIP DOCUMENT | 0001213900-26-038542 | View SEC Doc Filr Page |